Search

Your search keyword '"Myer, L."' showing total 884 results

Search Constraints

Start Over You searched for: Author "Myer, L." Remove constraint Author: "Myer, L."
884 results on '"Myer, L."'

Search Results

201. Guidelines for the transfer of people living with HIV attending primary healthcare facilities in South Africa: a scoping review.

202. Mpox in Pregnancy - Risks, Vertical Transmission, Prevention, and Treatment.

203. "I managed to stand on my own. I saved my baby's life.": qualitative analysis of birth experiences from women living with HIV in Cape Town, South Africa.

204. Subclinical Myocardial Fibrosis in South African Youth With HIV: Results From the CTAAC-Heart Study.

205. Clinical, pharmacological, and qualitative characterization of drug-drug interactions in pregnant women initiating HIV therapy in Sub-Saharan Africa.

206. An observational cohort study to investigate the impact of dolutegravir in pregnancy and its obesogenic effects on the metabolic health of women living with HIV and their children: Study protocol.

207. Peripartum mobility and maternal/child separation among women living with HIV in South Africa.

208. Cardioprotective effects of early versus late initiated antiretroviral treatment in adolescents with perinatal HIV-1 infection.

209. Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort study.

210. Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV.

211. Transfers between health facilities of people living with diabetes attending primary health care services in the Western Cape Province of South Africa: A retrospective cohort study.

212. Prevention of congenital syphilis within antenatal PrEP services in South Africa: missed opportunities.

213. ART history prior to conception: trends and association with postpartum disengagement from HIV care in Khayelitsha, South Africa (2013-2019): a retrospective cohort study.

214. Obesity is South Africa's new HIV epidemic.

215. The potential benefits of long-acting injectable cabotegravir in pregnant and breastfeeding women and their infants.

216. Support, not blame: safe partner disclosure among women diagnosed with HIV late in pregnancy in South Africa and Uganda.

217. Effect of prior tuberculosis on cardiovascular status in perinatally HIV-1-infected adolescents.

218. Cardioprotective effects of antiretroviral treatment in adolescents with perinatal HIV infection are heterogeneous depending on age at treatment initiation.

219. Inflammatory markers in pregnancy are associated with postpartum weight in South African women living with HIV on antiretroviral therapy.

220. Cardiometabolic Health in Pregnancy and Postpartum: Findings From a Prospective Cohort Study in South Africa.

221. Point-of-care testing for sexually transmitted infections and HIV pre-exposure prophylaxis among pregnant women in South Africa, 2021-2022: randomised controlled trial.

222. "So that's why I found PrEP to be safest way to protect yourself": exploring IPV experiences and impact on HIV prevention among pregnant and postpartum women in Cape Town, South Africa.

223. Measurement of body composition in postpartum South African women living with and without HIV infection.

224. Comparing a point-of-care urine tenofovir lateral flow assay to self-reported adherence and their associations with viral load suppression among adults on antiretroviral therapy.

225. Pregnancy outcomes following self-reported and objective-measured exposure to oral preexposure prophylaxis in South Africa.

226. The Determinants of Elevated Pathobiological Determination of Atherosclerosis in Youth Risk Score in Perinatally HIV-Infected Adolescents in South Africa.

227. Experiences of transfer of care among postpartum women living with HIV attending primary healthcare services in South Africa.

228. Maternal and birth outcomes in pregnant people with and without HIV in the Western Cape, South Africa.

229. Changes in the Vaginal Microbiome During Pregnancy and the Postpartum Period in South African Women: a Longitudinal Study.

230. Prevalence of obesity, hypertension and diabetes among people living with HIV in South Africa: a systematic review and meta-analysis.

231. Womandla Health: development and rationale of a behavioral intervention to support HIV treatment adherence among postpartum women in South Africa.

232. Why do Integrated Maternal HIV and Infant Healthcare Services work? A Secondary Analysis of a Randomised Controlled Trial in South Africa.

233. Integration of HIV pre-exposure prophylaxis (PrEP) services for pregnant and breastfeeding women in eight primary care clinics: results of an implementation science study.

234. Postnatal clubs: Implementation of a differentiated and integrated model of care for mothers living with HIV and their HIV-exposed uninfected babies in Cape Town, South Africa.

235. Mobility during the post-partum period and viraemia in women living with HIV in South Africa.

236. Associations of HIV and antiretroviral therapy with gestational diabetes in South Africa.

237. Maternal weight trajectories and associations with infant growth in South African women.

238. No increased in utero and peripartum HIV acquisition risk in HIV-exposed preterm infants.

239. Children of a syndemic: co-occurring and mutually reinforcing adverse child health exposures in a prospective cohort of HIV-affected mother-infant dyads in Cape Town, South Africa.

240. Acceptability and Feasibility of Providing Adherence Feedback Based on Tenofovir Diphosphate in Dried Blood Spots: Results from a Pilot Study Among Patients and Providers in Cape Town, South Africa.

241. Evaluating the use of oral pre-exposure prophylaxis among pregnant and postpartum adolescent girls and young women in Cape Town, South Africa.

242. Left ventricular remodeling and its correlates among adolescents with perinatally acquired HIV in South Africa.

243. Comparing Predictive Ability of Two Objective Adherence Measures in a Community-Based Cohort on Antiretroviral Therapy in South Africa: Tenofovir Diphosphate Concentrations and Electronic Adherence Monitors.

244. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.

245. Smartphone Ownership and Usage Among Pregnant Women Living With HIV in South Africa: Secondary Analysis of CareConekta Trial Data.

246. Positive attitudes toward adoption of a multi-component intervention strategy aimed at improving HIV outcomes among adolescents and young people in Nampula, Mozambique: perspectives of HIV care providers.

247. Persistent accelerated epigenetic ageing in a longitudinal cohort of vertically infected HIV-positive adolescents.

248. The Implementation of a GPS-Based Location-Tracking Smartphone App in South Africa to Improve Engagement in HIV Care: Randomized Controlled Trial.

249. Cost-effectiveness of point-of-care versus centralised, laboratory-based nucleic acid testing for diagnosis of HIV in infants: a systematic review of modelling studies.

250. Preferences and acceptability for long-acting PrEP agents among pregnant and postpartum women with experience using daily oral PrEP in South Africa and Kenya.

Catalog

Books, media, physical & digital resources